Evidence map›Paper›PMID 38850439›Full record

ArticleEndocrine2024

Exploring risk factors of severe pituitary apoplexy: Insights from a multicenter study of 71 cases.

Pablo Garcia-Feijoo, Carlos Perez Lopez, Igor Paredes, Alberto Acitores Cancela, Cristina Alvarez-Escola, Maria Calatayud, Alfonso Lagares, Maria Soledad Librizzi, Victor Rodriguez Berrocal, Marta Araujo-Castro

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Endocrine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Pablo Garcia-FeijooDepartment of Neurosurgery, Hospital Universitario La Paz, Madrid, Spain. g.feijoo.neurosurgery@gmail.com.ORCID 0000-0002-9052-2421
Carlos Perez LopezDepartment of Neurosurgery, Hospital Universitario La Paz, Madrid, Spain.
Igor ParedesDepartment of Neurosurgery, Hospital Universitario Doce de Octubre, Facultad de Medicina, Departamento de Cirugía, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Alberto Acitores CancelaDepartment of Neurosurgery, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Cristina Alvarez-EscolaDepartment of Endocrinology & Nutrition, Hospital Universitario La Paz, Madrid, Spain.
Maria CalatayudDepartment of Endocrinology & Nutrition, Hospital Universitario Doce de Octubre, Madrid, Spain.
Alfonso LagaresDepartment of Neurosurgery, Hospital Universitario Doce de Octubre, Facultad de Medicina, Departamento de Cirugía, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Maria Soledad LibrizziDepartment of Endocrinology & Nutrition, Hospital Universitario Doce de Octubre, Madrid, Spain.
Victor Rodriguez BerrocalDepartment of Neurosurgery, Hospital Universitario Ramón y Cajal, Madrid, Spain.
Marta Araujo-CastroDepartment of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal. Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), Madrid, Spain. marta.araujo@salud.madrid.org.ORCID 0000-0002-0519-0072

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo identify clinical and radiological factors associated with a higher risk of developing a severe pituitary apoplexy (PA).

methodsMulticenter retrospective study of patients presenting with clinical PA in three Spanish tertiary hospitals of Madrid between 2008 and 2022. We classified PA as severe when presenting with an altered level of consciousness (Glasgow Coma Scale (GCS) < 15) or visual involvement.

resultsA total of 71 PA cases were identified, of whom 80.28% (n = 57) were classified as severe PA. The median age was 60 (18 to 85 years old) and 67.6% (n = 48) were male. Most patients had macroadenomas, except for one patient with a microadenoma of 9 mm. Headache was the most common presenting symptom (90.1%) and anticoagulation was the most frequent predisposing risk factor, but it was not associated with a higher risk for severe PA (odds ratio [OR] 1.13 [0.21-5.90]). Severe cases were associated with male gender (OR 5.53 [1.59-19.27]), tumor size >20 mm (OR 17.67 [4.07-76.64]), and Knosp grade ≥2 (OR 9.6 [2.38-38.73]). In the multivariant analysis, the only variables associated with a higher risk for severe PA were tumor size and Knosp grade. Surgery was more common in severe PA than in non-severe (91.2% vs. 64.3%, P = 0.009).

conclusionA tumor size >20 mm and cavernous sinus invasion are risk factors for developing a severe PA. These risk factors can stratify patients at a higher risk of a worse clinical picture, and subsequently, more need of decompressive surgery.

Indexed as

AdenomaPituitary ApoplexyPituitary NeoplasmsAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesRisk FactorsSeverity of Illness IndexSpainYoung Adultheadachehypopituitarismpituitary apoplexypituitary tumorsseveretranssphenoidal surgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.